57 /100
MEDIUM RISK
Score updated Feb 26, 2026
BBOT
BridgeBio Oncology Therapeutics, Inc.

DilutionScore™ measures dilution risk across 5 factors. Lower scores indicate higher risk of share dilution.

🔔 Get alerts when BBOT's score changes →
📊 Score Breakdown
📋 Offering Ability
40
💰 Cash Runway
100
📊 Float Risk
40
⚠️ Warrant Exposure
85
🔄Convertible Debt
💹 Market Data
Market Cap$819.88M
Shares Outstanding79.99M
Float31.11M
Cash$468.28M
Debt$2.89M
Short InterestN/A
🏛 Institutional Holdings
41 institutional holders · 56.81M shares
#1 Cormorant Asset Management, LP 17.88M shares
#2 DEERFIELD MANAGEMENT COMPANY, L.P. 4.89M shares
#3 Omega Fund Management, LLC 3.29M shares
+ 17 more holders Sign up free to view →
📉 Short Interest
Short Interest2.18M
Days to Cover4.4
% of Float7.0%
FINRA data as of Jan 15, 2026
📁 Recent SEC Activity
No recent SEC insights
📰 Recent News
Track BBOT Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking BBOT — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required